A detailed history of Keynote Financial Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Keynote Financial Services LLC holds 41,046 shares of ABBV stock, worth $7.78 Million. This represents 5.89% of its overall portfolio holdings.

Number of Shares
41,046
Previous 40,782 0.65%
Holding current value
$7.78 Million
Previous $7.43 Billion 5.2%
% of portfolio
5.89%
Previous 6.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $40,864 - $47,720
264 Added 0.65%
41,046 $7.04 Billion
Q1 2024

Jun 13, 2024

BUY
$159.82 - $182.1 $6.52 Million - $7.43 Million
40,782 New
40,782 $7.43 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.